The drug is being developed for the treatment of chronic moderate-to-severe malignant (cancer-related) and non-malignant pain, such as osteoarthritis and lower-back. Alpharma has developed a proprietary technology that
Practitioners at the Clinic for Special Children in Pennsylvania are using GeneChip microarrays developed by Affymetrix to discover the genetic cause of diseases at an unprecedented pace. The
The company, which has seen its proprietary drug Viprovex treat other strains of influenza in animal models, is currently pursuing government and military collaborations to test Viprovex on
Scientists from the Mount Sinai School of Medicine developed a technique to insert genes into non-coding regions of the genome so there is no danger of interfering with
Zyflo is the only drug in the class of 5-lipoxygenase (5-LO) inhibitors approved for marketing by the FDA. The drug interrupts the 5-LO cascade, the products of which
The study, which is not intended for registration, showed that in all stage IV patients, median survival improved by more than 50% in the Oncophage-treated arm compared with
The investigators, that published findings from the study in Nature Genetics, believe this discovery will be of great interest to biomedical and pharmaceutical researchers because of an already
The majority of patients with advanced stage disease who were treated with the combination regimen demonstrated an improvement on imaging studies, according to results published in the journal
According to figures cited by the company, total annual market sales for Amaryl tablets were $349.5 million. Glimepiride is indicated as an adjunct to diet and exercise to
Based on the National Cancer Institute (NCI) pharmacodynamics data published in 1996, daily consumption of 1,200ml of green tea containing 710mcg/ml epigallocatechin gallate (EGCG), which is used to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.